Everett  Cunningham net worth and biography

Everett Cunningham Biography and Net Worth

Insider of Exact Sciences

Everett Cunningham joined as the Chief Commercial Officer in 2021.  Mr. Cunningham brings over 25 years of progressive responsibility in pharmaceuticals and medical services and a commitment to leadership excellence.  Prior to joining Exact Sciences, Mr. Cunningham served as President & CEO of GE Healthcare’s U.S. & Canada region.  Before joining GE, Mr. Cunningham served as the Senior Vice President, Commercial, at Quest Diagnostics, where he was responsible for global commercial sales, marketing, and commercial operations.

Mr. Cunningham also served in numerous senior leadership roles at Pfizer, including Regional President, Established Products for Asia Pacific, Senior Director of Worldwide Learning and Development, Senior Director of Business Operations, Vice President Sales for U.S. Pharmaceuticals, and Vice President of Global Corporate Human Resources.

Mr. Cunningham earned his bachelor’s degree in economics from Northwestern University.

What is Everett Cunningham's net worth?

The estimated net worth of Everett Cunningham is at least $2.18 million as of October 12th, 2023. Mr. Cunningham owns 37,909 shares of Exact Sciences stock worth more than $2,180,905 as of February 25th. This net worth evaluation does not reflect any other investments that Mr. Cunningham may own. Additionally, Mr. Cunningham receives a salary of $1,340,000.00 as Insider at Exact Sciences. Learn More about Everett Cunningham's net worth.

How old is Everett Cunningham?

Mr. Cunningham is currently 58 years old. There are 4 older executives and no younger executives at Exact Sciences. Learn More on Everett Cunningham's age.

What is Everett Cunningham's salary?

As the Insider of Exact Sciences Co., Mr. Cunningham earns $1,340,000.00 per year. The highest earning executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who commands a salary of $1,540,000.00 per year. Learn More on Everett Cunningham's salary.

How do I contact Everett Cunningham?

The corporate mailing address for Mr. Cunningham and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on Everett Cunningham's contact information.

Has Everett Cunningham been buying or selling shares of Exact Sciences?

Everett Cunningham has not been actively trading shares of Exact Sciences over the course of the past ninety days. Most recently, Everett Cunningham sold 13,007 shares of the business's stock in a transaction on Thursday, October 12th. The shares were sold at an average price of $66.49, for a transaction totalling $864,835.43. Following the completion of the sale, the insider now directly owns 37,909 shares of the company's stock, valued at $2,520,569.41. Learn More on Everett Cunningham's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, insiders at the medical research company sold shares 34 times. They sold a total of 135,771 shares worth more than $9,578,961.31. The most recent insider tranaction occured on February, 21st when insider Jacob A Orville sold 1,078 shares worth more than $66,297.00. Insiders at Exact Sciences own 1.3% of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 2/21/2024.

Everett Cunningham Insider Trading History at Exact Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/12/2023Sell13,007$66.49$864,835.4337,909View SEC Filing Icon  
10/12/2022Sell16,872$31.37$529,274.6418,654View SEC Filing Icon  
See Full Table

Everett Cunningham Buying and Selling Activity at Exact Sciences

This chart shows Everett Cunningham's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $57.45
Low: $57.45
High: $57.45

50 Day Range

MA: $66.54
Low: $57.53
High: $75.72

2 Week Range

Now: $57.45
Low: $57.33
High: $100.77


1,742 shs

Average Volume

1,905,062 shs

Market Capitalization

$10.43 billion

P/E Ratio


Dividend Yield